Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 3
1980 1
1981 2
1982 2
1983 1
1984 3
1986 1
1987 2
1990 3
1991 1
1992 1
1993 2
1994 6
1995 4
1996 6
1997 16
1998 9
1999 8
2000 10
2001 7
2002 7
2003 12
2004 9
2005 10
2006 7
2007 3
2008 4
2009 7
2010 8
2011 10
2012 10
2013 6
2014 7
2015 5
2017 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.
de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A. de Gramont A, et al. Among authors: cortes funes h. J Clin Oncol. 2000 Aug;18(16):2938-47. doi: 10.1200/JCO.2000.18.16.2938. J Clin Oncol. 2000. PMID: 10944126 Corrected and republished. Clinical Trial.
Granulocyte growth factors: achieving a consensus.
Boogaerts M, Cavalli F, Cortés-Funes H, Gatell JM, Gianni AM, Khayat D, Levy Y, Link H. Boogaerts M, et al. Among authors: cortes funes h. Ann Oncol. 1995 Mar;6(3):237-44. doi: 10.1093/oxfordjournals.annonc.a059152. Ann Oncol. 1995. PMID: 7542020 Free article. Review.
The role of RANK-ligand inhibition in cancer: the story of denosumab.
Castellano D, Sepulveda JM, García-Escobar I, Rodriguez-Antolín A, Sundlöv A, Cortes-Funes H. Castellano D, et al. Among authors: cortes funes h. Oncologist. 2011;16(2):136-45. doi: 10.1634/theoncologist.2010-0154. Epub 2011 Feb 1. Oncologist. 2011. PMID: 21285392 Free PMC article. Review.
Targeted molecular mechanisms of epoetin alfa.
Langer CJ, Hirsch FR, Cortés-Funes H, Sawyer ST, Thatcher N. Langer CJ, et al. Among authors: cortes funes h. Lung Cancer. 2003 Aug;41 Suppl 1:S133-45. doi: 10.1016/s0169-5002(03)00157-0. Lung Cancer. 2003. PMID: 12867072 Review.
Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer.
Bellmunt J, Guillem V, Paz-Ares L, González-Larriba JL, Carles J, Albanell J, Tabernero JM, Cortés-Funes H, Baselga J. Bellmunt J, et al. Among authors: cortes funes h. Eur J Cancer. 2000 Jul;36 Suppl 2:17-25. doi: 10.1016/s0959-8049(00)00081-2. Eur J Cancer. 2000. PMID: 10908844 Review.
Clinical practice guidelines on antiemetics in oncology.
Aranda Aguilar E, Constenla Figueiras M, Cortes-Funes H, Diaz-Rubio García E, Gascon Vilaplana P, Guillém V, Martin-Algarra S. Aranda Aguilar E, et al. Among authors: cortes funes h. Expert Rev Anticancer Ther. 2005 Dec;5(6):963-72. doi: 10.1586/14737140.5.6.963. Expert Rev Anticancer Ther. 2005. PMID: 16336087 Review.
185 results